|
Miltenyi Biotec
cd133 micro beads ![]() Cd133 Micro Beads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd133+microbead+kit/CD133+MicroBead+Kit%2C+human+-+lyophilized/pm28000861-56-15-19 Average 95 stars, based on 1 article reviews
cd133 micro beads - by Bioz Stars,
2026-10
95/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
cd133 microbeads ![]() Cd133 Microbeads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd133+microbead+kit/CD133+MicroBead+Kit+-+Tumor+Tissue%2C+human/pmc13051525-212-9-12 Average 93 stars, based on 1 article reviews
cd133 microbeads - by Bioz Stars,
2026-10
93/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
indirect cd133 microbead kit ![]() Indirect Cd133 Microbead Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd133+microbead+kit/Indirect+CD133+MicroBead+Kit%2C+human/pmc06436701-58-15-19 Average 94 stars, based on 1 article reviews
indirect cd133 microbead kit - by Bioz Stars,
2026-10
94/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
microbead kit ![]() Microbead Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd133+microbead+kit/CD133+MicroBead+Kit+-+Hematopoietic+Tissue%2C+human/pm37455406-88-20-22 Average 94 stars, based on 1 article reviews
microbead kit - by Bioz Stars,
2026-10
94/100 stars
|
Buy from Supplier |
Image Search Results
Journal: International journal of oncology
Article Title: CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer.
doi: 10.3892/ijo.2016.3812
Figure Lengend Snippet: Figure 1. The expression of CD133 in lung cancer and normal lung tissues. Original values are presented as log2 ratios. Spots showing the level of CD133 mRNA in NSCLC and normal tissues. (A) GSE10072. (B) GSE40275. (C) GSE63459; *p<0.05, **p<0.01 and ***p<0.001. (D) Correlation between CD133 and CXCR4 in GSE30219.
Article Snippet: Cells were incubated at 4 ̊C with 100 μl FcR blocking reagent and 100 μl
Techniques: Expressing
Journal: International journal of oncology
Article Title: CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer.
doi: 10.3892/ijo.2016.3812
Figure Lengend Snippet: Figure 2. CD133 and CXCR4 are highly expressed in NSCLC patients with metastasis. (A) Representative images of immunohistochemistry staining (mag- nification, x400) of NSCLC patients. (a) CD133 low expression; (b) CD133 high expression; (c) CXCR4 low expression; (d) CXCR4 high expression. Positive staining ratio of CD133 (B)/CXCR4 (C) in metastatic and non-metastatic NSCLC patients. Positive staining score of CD133 (D)/CXCR4 (E) in metastatic and non-metastatic NSCLC patients. (F) Correlation results of CD133 and CXCR4. (G) Correlation analysis between CD133/CXCR4 co-expression and disease- free survival (red and black curves indicate high and low CD133/CXCR4 co-expression groups of patient death, respectively; *p<0.05).
Article Snippet: Cells were incubated at 4 ̊C with 100 μl FcR blocking reagent and 100 μl
Techniques: Immunohistochemistry, Staining, Expressing
Journal: International journal of oncology
Article Title: CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer.
doi: 10.3892/ijo.2016.3812
Figure Lengend Snippet: Figure 3. CD133 enhances A549 cells proliferation. (A) Effectiveness of magnetic cell sorting was verified by immunofluorescence assay (magnification, x400). Red and blue indicate CD133 expression and cell nucleus, respectively. (B) Formation of colonies by A549 cell lines after 2-week incubation. (C and D) Cell proliferation capacity was determined in A549 cells, CD133+ A549 cells and CD133-A549 cells by CCK8 assays.
Article Snippet: Cells were incubated at 4 ̊C with 100 μl FcR blocking reagent and 100 μl
Techniques: FACS, Immunofluorescence, Expressing, Incubation
Journal: International journal of oncology
Article Title: CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer.
doi: 10.3892/ijo.2016.3812
Figure Lengend Snippet: Figure 4. CXCR4 is upregulated by CD133. Silencing effectiveness of CD133 siRNA was verified by qPCR (A) and western blot analysis (B). (C) Expression of CXCR4 after treatment with CD133 siRNA (50 nM, 48 h) by qPCR analysis. (D) Western blot analysis for the expression of CXCR4 after treatment with CD133 siRNA (50 nM, 72 h). β-actin as a loading control. (E) The statistics of (D). All experiments were performed in triplicate. ***p<0.001.
Article Snippet: Cells were incubated at 4 ̊C with 100 μl FcR blocking reagent and 100 μl
Techniques: Western Blot, Expressing, Control
Journal: International journal of oncology
Article Title: CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer.
doi: 10.3892/ijo.2016.3812
Figure Lengend Snippet: Figure 5. CD133+CXCR4+ promotes EMT process in NSCLC cells. (A) Transwell assay for the invasion of CD133-CXCR4+, CD133+CXCR4- and CD133+CXCR4+ cells. (B) Western blot assay for the expression of E-cadherin and Vimentin in CD133-CXCR4+, CD133+CXCR4- and CD133+CXCR4+ cells. (C) qPCR for the expression of E-cadherin, Vimentin, Snail, Slug and Twist in A549/CD133+, A549/CD133+ shRNA-NC, A549/CD133+ shRNA-CXCR4 and A549/CD133+ with amd3100. (D and E) RT-PCR for the expression of E-cadherin, Vimentin, Snail, Slug and Twist in A549/CD133+, A549/CD133+ shRNA-NC and A549/CD133+
Article Snippet: Cells were incubated at 4 ̊C with 100 μl FcR blocking reagent and 100 μl
Techniques: Transwell Assay, Western Blot, Expressing, shRNA, Reverse Transcription Polymerase Chain Reaction
Journal: International journal of oncology
Article Title: CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer.
doi: 10.3892/ijo.2016.3812
Figure Lengend Snippet: Figure 6. Vimentin is positively associated with CD133/CXCR4 co-expression. (A) Representative images of immunohistochemistry staining (magnification, x400) of NSCLC patients. (a) E-cadherin low expression; (b) E-cadherin high expression; (c) Vimentin low expression; (d) Vimentin high expression. Positive staining ratio of E-cadherin (B)/Vimentin (C) in metastatic and non-metastatic NSCLC patients. Correlation analysis for E-cadherin (D) or Vimentin (E) with CD133/CXCR4 co-expression in NSCLC patients.
Article Snippet: Cells were incubated at 4 ̊C with 100 μl FcR blocking reagent and 100 μl
Techniques: Expressing, Immunohistochemistry, Staining
Journal: Genes to Cells
Article Title: Functional Role of COP1 Gene in Hepatocellular Carcinoma Lipid Metabolism and Stemness
doi: 10.1111/gtc.70108
Figure Lengend Snippet: COP1 knockdown reduces motility, and stemness in HCC cells. (a‐b) Migration (a) or invasion (b) assay showing reduced motility in Huh7 and HepG2 cells treated with COP1‐siRNA, as quantified by the relative migration or invaded area. Statistical significance: *, p < 0.05; ** p < 0.01; *** p < 0.001 vs. control. (c) Sphere formation assay images and quantitative data from Huh7 and HepG2 cells, demonstrating a decrease in both the number and size of spheres in COP1‐siRNA‐treated cells. (d) Sphere formation assay images and quantitative data from PLC/PRF/5 CD133+ cells. Compared to the control grpup, both the sphere number and size decreased upon COP1‐siRNA treatment. Scale bar, 100 μm Statistical significance: *, p < 0.05; *** p < 0.001 vs. control.
Article Snippet: The cells were treated with FcR Blocking Reagent and
Techniques: Knockdown, Migration, Control, Tube Formation Assay
Journal: PLoS ONE
Article Title: Reduced variability of neural progenitor cells and improved purity of neuronal cultures using magnetic activated cell sorting
doi: 10.1371/journal.pone.0213374
Figure Lengend Snippet: (A) Representative immunofluorescence images from one NPC line demonstrating a reduction in CD271+ cells and an enrichment of CD133+ positive cells following both FACS and MACS compared to unsorted cells. Cell nuclei are labelled with DAPI. Scale bar = 100μm, N = 6. (B) Combined flow cytometry analysis of percent CD271+, CD271- and CD271-/CD133+ cells from 100% live cells (DAPI negative population) comparing unsorted, FACS and MACS conditions. (C) Flow cytometry analysis in B presented as individual cell lines. (D) Reduction in CD271+ cell variability following MACS compared to unsorted cell s . **p<0.01 Variance F-test. (E) Fold change expression of stress-associated genes in cells following FACS compared to MACS. Dotted line denotes equal expression at fold change = 1. (F) Quantification of the percentage surface area covered by live cells imaged in D . (G) Absorbance read at 450nm of LDH assay carried out on media supernatant collected from cells 24 hours following either FACS or MACS sorting. (H) Cell viability assessed by Calcein Violet staining 24 hours following standard passage (unsorted) or following sorting by either FACS or MACS in two representative NPC lines with different survival responses. Scale bar = 100μm, *p<0.05, n.s = not significant. Error bars ± SEM.
Article Snippet: CD271- cells were re-pelleted and re-suspended in fresh MACS Separation Buffer, then labelled using the
Techniques: Immunofluorescence, Flow Cytometry, Expressing, Lactate Dehydrogenase Assay, Staining
Journal: PLoS ONE
Article Title: Reduced variability of neural progenitor cells and improved purity of neuronal cultures using magnetic activated cell sorting
doi: 10.1371/journal.pone.0213374
Figure Lengend Snippet: (A-B). Clustering of individual cell lines using multidimensional scaling analysis based on gene expression profiles from custom designed Taqman microfluidic cards. (A)Both FACS (red) and MACS (blue) increase gene expression homogeneity between NPC lines (indicated by black circle) compared to unsorted cells (green). (B) MACS (triangles) also improves gene expression homogeneity across different neuron populations (red), as indicated by the red oval, compared to unsorted cells (squares). NPC populations are colored in blue and the homogeneous cluster is indicated by a blue circle, FACS NPCs are circles. Neurons differentiated from the unsorted F12444-3-2 NPC line that failed both FACS and MACS sorting due to low levels of CD271-/CD133+ cells are indicated with a black arrow. (C) Comparison of gene expression of glial and neuronal specific markers in neurons derived from MACS NPCs compared to neurons derived from unsorted NPCs. (D) Representative immunofluorescence images of neurons derived from NPCs demonstrating the enrichment of neuronal markers Tuj1, NeuN and Tau, as well as the depletion of glial markers GFAP and S100β when differentiated from MACS NPCs compared to unsorted NPCs. Cell nuclei are labelled with DAPI. Scale bar = 100μm, N = 5. (E-F) Flow cytometry analysis for neuronal marker TUJ1 (E) and NeuN (F) on neurons derived from MACS NPCs compared to neurons from unsorted NPCs. Relative index for each marker is generated by the multiplication of total number of fluorescent positive cells and its median fluorescence intensity. (G) Relative index of astrocyte marker, S100β by flow cytometry analysis. *p<0.05, **p<0.01, n.s = not significant. Error bars ± SEM.
Article Snippet: CD271- cells were re-pelleted and re-suspended in fresh MACS Separation Buffer, then labelled using the
Techniques: Gene Expression, Comparison, Derivative Assay, Immunofluorescence, Flow Cytometry, Marker, Generated, Fluorescence
Journal: PLoS ONE
Article Title: Reduced variability of neural progenitor cells and improved purity of neuronal cultures using magnetic activated cell sorting
doi: 10.1371/journal.pone.0213374
Figure Lengend Snippet: (A) Representative immunofluorescence images from a late passage NPC line demonstrating a visible reduction in CD271+ cells and an enrichment of CD133+ positive cells, as well as an enrichment of NPC markers following MACS. Cell nuclei are labelled with DAPI. Scale bar = 100μm. (B-C) Percentage of late passage NPCs positive for SOX2 (B) and NESTIN (C) as measured by flow cytometry analysis. The summary result is shown in unsorted and MACS NPCs compared to the secondary antibody control and CD271+ cells by pooled results of individual cell lines from . (D) Percent NESTIN+ cells by flow cytometry analysis in early (p2-3) and late passage (p10-13) NPCs. (E) Clustering of individual late passage NPC lines using multidimensional scaling analysis based on gene expression profiles from custom designed Taqman microfluidic cards. MACS (triangles) improves homogeneity across late passage (blue) cell lines compared to unsorted cell lines (squares), and exhibits similar gene expression profiles as early passage (red) MACS and FACS (circles) NPCs, indicated by a dotted circle. (F) Representative immunofluorescence images of neurons differentiated from one late passage NPC line demonstrating an enrichment of neuronal specific markers following MACS, but a maintenance of expression of glial-specific markers. Cell nuclei are labelled with DAPI. Scale bar = 100μm. (G) Comparison of gene expression of glial and neuronal specific markers in neurons derived from late passage MACS NPCs compared to neurons derived from early passage NPCs. *p<0.05, **p<0.01, ***p<0.001. Error bars ± SEM.
Article Snippet: CD271- cells were re-pelleted and re-suspended in fresh MACS Separation Buffer, then labelled using the
Techniques: Immunofluorescence, Flow Cytometry, Control, Gene Expression, Expressing, Comparison, Derivative Assay